D. Spielsinger

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

Sean M. McBride, Eric J. Sherman, C. Jillian Tsai et al. · Journal of Clinical Oncology · 2020 · 394 citations · Full text

Medicine, Oncology, Radiation Oncology +15

A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC).

Sean M. McBride, Eric J. Sherman, C. Jillian Tsai et al. · Journal of Clinical Oncology · 2018 · 62 citations

Medicine, Oncology, Radiation Oncology +15

Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease

Thomas H. Beckham, Paul B. Romesser, A Groen et al. · Thyroid · 2018 · 35 citations · Full text

Medicine, Oncology, Radiation Oncology +14